Thrombus Formation During Pulmonary Vein Ablation: When Routine Turns Risky Authors: Álvaro Barranco de Santiago, Mireia Pozo-Albiol, Samira Martínez-Otero, Jean-Baptiste Guichard, María José Carretero, Marc Giménez-Milà Published: 2026 ABSTRACT ABSTRACTAtrial fibrillation (AF) is the most common sustained arrhythmia and a major contributor to thromboembolic events. Pulmonary vein isolation is the main therapy to achieve rhythm control, and intraoperative transesophageal echocardiography (iTEE) enhances procedural safety by guiding transseptal puncture and detecting possible complications such as thrombi formation. Nevertheless, intraprocedural catheter thrombosis remains remarkably infrequent and is poorly documented in medical literature. A 59-year-old man with paroxysmal AF and a prior transient ischemic attack, under anticoagulation with apixaban, presented for redo pulmonary vein ablation. Due to premature interruption of anticoagulation, iTEE revealed a large thrombus attached to the ablation catheter after transseptal puncture, so the procedure was postponed and the patient recovered without complications. A second ablation under uninterrupted anticoagulation was performed 4 weeks later, with successful isolation of all pulmonary veins and restoration of stable sinus rhythm. Intraprocedural catheter thrombosis is a rare but potentially life-threatening complication not currently addressed in AF management guidelines. This case underscores the pivotal role of iTEE in the early detection of this unexpected event, supporting its use for both procedural guidance and surveillance of thromboembolic complications. Effective anticoagulation management, favoring uninterrupted anticoagulant use, remains essential to mitigate thromboembolic risk. Overall, this report highlights the importance of integrating advanced imaging and strict anticoagulation protocols to prevent catheter-related thrombotic events during AF ablation. INTRODUCTION Atrial fibrillation (AF) is one of the most prevalent sustained arrhythmia, affecting over 4.5% of the adult population.[1] Catheter ablation for pulmonary veins isolation is a cornerstone of rhythm control strategies. Although increasingly safe, it requires careful anticoagulation and transseptal access to prevent thromboembolism. In this context, intraoperative transesophageal echocardiography (iTEE) provides real-time, high-resolution imaging enhancing both the precision and safety of the procedure. Beyond guiding transseptal puncture, iTEE plays a pivotal role in detecting intracardiac thrombi and evaluating left atrial anatomy, particularly in patients with prothrombotic risk factors such as patent foramen ovale (PFO), spontaneous echo contrast, or prior embolic events. The authors aim to describe a single case of intraprocedural catheter thrombosis during percutaneous pulmonary vein catheter ablation, discussing the role of iTEE for the detection of this complication and its multidisciplinary management. CASE REPORT PRESENTATION A 59-year-old man, with past medical history of paroxysmal AF, presented with transient ischemic attack (TIA) 4 years ago and underwent a pulmonary vein ablation 3 years back. Since then, he had been under anticoagulation with apixaban and rhythm control with propafenone. In the current medical episode, he presented to the emergency room with fast AF. He was, therefore, rescheduled for a redo pulmonary vein radiofrequency (RF) ablation. In accordance with the local periprocedural protocol, the last dose of apixaban was scheduled to be held 12 hours before the procedure, but the patient inadvertently stopped it 24 hours before the procedure. After standard monitoring, the procedure was performed under general anesthesia and endotracheal intubation. Femoral venous access was obtained under ultrasound guidance. The initial iTEE did not show any endocavitary thrombus or pericardial effusion, but it did reveal the presence of spontaneous echo-contrast in the right atrium and a previously undiagnosed PFO with left to right shunt flow. A double transseptal puncture (one for the ablation catheter and a second one for mapping the left atrium) is standard of care in most of the centers as in our case. The first transeptal puncture was performed under iTEE guidance without any immediate complication. After the puncture, 100 IU/kg of intravenous sodium heparin was administered to achieve an activated coagulated time (ACT) of 300–350 seconds. Prior to the second transeptal puncture, an image compatible with a 3 cm thrombus attached to the tip of the catheter was observed [Figure 1a, b]. (a and b) Intraprocedural transesophageal echocardiography (iTEE). Red pointer: Thrombus attached to the catheter at the inferior Cavo-atrial isthmus. Yellow pointer: Thrombus attached to the catheter at the superior Cavo-atrial isthmus and in the RA Given the high thromboembolic risk due to the history of TIA and the presence of PFO, the medical team decided to withdraw all catheters under aspiration and postpone the ablation procedure. The final iTEE did not show any intracavitary thrombus or other hemorrhagic complications. Emergence from anesthesia took place uneventfully, and the patient was discharged 24 hours postprocedure without any neurological deficit. Given the recurrence of symptomatic AF, a repeat procedure was scheduled 4 weeks later. On this occasion, apixaban was continued without interruption, with the last dose administered 12 hours before the intervention. The second procedure was performed under general anesthesia and endotracheal intubation. No images suggestive of intracavitary thrombus, spontaneous echo contrast in the right atrium, or pericardial effusion were observed. A double-transseptal puncture was performed under fluoroscopic and TEE guidance. The patient remained hemodynamic stable throughout the procedure, and the four pulmonary veins were successfully isolated. He regained sinus rhythm and was discharged 24 hours after the procedure. Follow-up demonstrated permanent sinus rhythm and a favorable clinical evolution, without complications or recurrence of symptoms. DISCUSSION Historically, oral anticoagulation was stopped before AF ablation due to concerns about complications like tamponade, or vascular hemorrhagic complications. Nowadays, the ACC, AHA, and American College of Chest Physicians and Heart Rhythm Society recommend performing these procedures on uninterrupted or minimally interrupted oral anticoagulation.[2] Clinical trials and meta-analysis show similar outcomes in terms of safety and efficacy, with no significant difference in thromboembolic events or major bleeding.[2] Intraprocedural catheter thrombosis is a rare and underrecognized complication. Thromboembolic events occur in < 1% of catheter ablations, including pulmonary vein ablation.[2] There have also been identified venous thrombotic events associated with femoral vascular access[3] that can lead to pulmonary embolism. However, there are no published reports addressing intraprocedural catheter thrombosis during pulmonary vein ablation. In the case report we present, iTEE had a pivotal role in the early detection of this potentially life-threatening complication. The European Heart Rhythm Association (EHRA) Expert Consensus Statement on catheter and surgical ablation of AF, published in 2017, emphasizes the significance of iTEE during ablation of pulmonary veins, especially in the context of AF ablation.[4] Moreover, the main cardiac image societies, such as the American Society of Echocardiography, recommend the use of iTEE to rule out possible thrombus in the left-atrial appendage during the procedure.[5] iTEE is essential for transseptal puncture guidance, catheter positioning, and identifying anatomical variations. It also improves safety and accuracy while reducing risks like esophageal damage and tamponade during transseptal puncture. The group of Patel et al.[6] analyzed the data from a multicenter registry of patients undergoing pulmonary vein ablation on uninterrupted direct oral anticoagulants (DOACs) and concluded that ablation without iTEE is safe and feasible in high-risk patients, with possible clinical and economic benefits. However, as the investigation itself mentions, the results are limited to the group of patients who do not discontinue anticoagulation. Intracardiac echocardiography (ICE) can supplement or, in some cases, replace iTEE. It can be utilized during pulmonary vein ablation to assist in transseptal puncture and to detect potential complications.[78] The Heart Rhythm Society, in an expert consensus statement published in 2017, stated that ICE might be considered in patients who cannot undergo iTOE.[4] Other potential advantages of ICE are real-time procedural guidance, ablation lesion delivery, and the early detection of complications. Moreover, ICE enables the immediate recognition of complications without requiring general anesthesia. For patients with difficult airway or anesthesia contraindications, it may be a safer alternative. However, iTEE has essential advantages over ICE, specifically for the diagnosis of intracardiac thrombi, as it remains the gold standard for thrombus detection in the left atrial appendage, offering high specificity and sensitivity.[4] Regarding anticoagulation, there is a demonstrated association between periprocedural anticoagulation timing and thromboembolic risk. The COMPARE trial[9] found that interrupting warfarin was strongly associated with an increased risk of thromboembolic events. In contrast, continuing the therapy with no interruption was associated to lower rates of both bleeding and thromboembolic complications. As a result, the AHA and the ACC guidelines advise that catheter ablation can be performed during continued therapeutic anticoagulation while it can be done with continuous or short discontinuation of DOACs.[2] To sum up, intraprocedural catheter thrombosis is a rare but potentially life-threatening complication not currently addressed in AF management guidelines. This case underscores the pivotal role of iTEE in the early detection of this unexpected event, supporting its use for both procedural guidance and surveillance of thromboembolic complications. Effective anticoagulation management, favoring uninterrupted anticoagulant use, remains essential to mitigate thromboembolic risk. Overall, this report highlights the importance of integrating advanced imaging and strict anticoagulation protocols to prevent catheter-related thrombotic events during AF ablation. Conflict of interest Nil.